Cohen, J. Naked DNA points the way to vaccines. Science, vol. 259, pp. 1691-1692, Mar. 19, 1993.* |
Orkin et al. Report and recommendations of the panel to assess the NIH investment in research on gene therapy. Distributed by the National Institutes of Health, Bethesda, MD., Dec. 17, 1995.* |
Sequence Search of Seq. Id. No. 4, completed by the PTO's STIC in commercial databases on Sep. 23, 1997. Pp. 1 and 11-12 of a first set, and pp. 1-2 or a second set.* |
Abe et al., “Molecular Characterization of a Novel Metabotropic Glutamate Receptor mGluR5 Coupled to Inositol Phosphate/Ca2+ Signal Transduction,” J. Biol. Chem. 267:13361-13368 (1992). |
Adelman et al., “In Vitro Deletional Mutagenesis for Bacterial Production of the 20,000-Dalton Form of Human Pituitary Growth Hormone,” DNA 2(3):183-193 (1983). |
Allan et al., “Hormone and Antihormone Induce Distant Conformational Changes Which Are Central to Steroid Receptor Activation,” J. Biol. Chem. 267:19513-19520 (1992). |
Allan et al., “Ligand-dependent conformational changes in the progesterone receptor are necessary for events that follow DNA binding,” Proc. Natl. Acad. Sci. USA 89:11750-11754 (1992). |
Archer et al., “Transcriptional Factor Loading on the MMTV Promoter: A Bimodal Mechanism for Promoter Activation,” Science 255:1573-1576 (1992). |
Baniahmad et al., “A transferable silencing domain is present in the thyroid hormone receptor, in the v-erbA oncogene product and in the retinoic acid receptor,” EMBO J. 11:1015-1023 (1992). |
Baniahmad et al., “Enhancement of Human Estrogen Receptor Activity by SPT6: A Potential Coactivator,” Molecular Endocrinology 9:34-43 (1995). |
Baniahmad et al., “the τ4 Activation Domain of the Thyroid Hormone Receptor Is Required for Release of a Putative Corepressor(s) Necessary for Transcriptional Silencing,” Molecular and Cellular Biology 15:76-86 (1995). |
Baniahmad et al., “Interaction of human thyroid hormone receptor β with transcription factor TFIIB may mediate target gene derepression and activation by thyroid hormone,” Proc. Natl. Acad. Sci. USA 90:8832-8836 (1993). |
Bayer et al., “The Avidin-Biotin Complex in Affinity Cytochemistry,” Methods in Enzymology 62:308-319 (1979). |
Beekman et al., “A rapid one-step method to purify baculovirus-expressed human estrogen receptor to be used in the analysis of the oxytocin promoter,” Gene 146:285-289 (1994). |
Beekman et al., “Transcriptional Activation by the Estrogen Receptor Requires a Conformational Change in the Ligand Binding Domain,” Molecular Endocrinology 7:1266-1274 (1993). |
Benoist and Chambon, “In vivo sequence requirements of the SV40 early promoter region,” Nature 290:304-310 (1981). |
Berkenstam et al., “Cooperativity in Transactivation between Retinoic Acid Receptor and TFIID Requires an Activity Analogous to E1A,” Cell 69:401-412 (1992). |
Bocquel et al., “The contribution of the N- and C-terminal regions of steroid receptors to activation of transcription is both receptor and cell-specific,” Nucleic Acids Research 17:2581-2595 (1989). |
Bollon and Stauver, “DNA Transformation Efficiency of Various Bacterial and Yeast Host-Vector Systems,” Journal of Clinical Hematology and Oncology 10(2&3):39-48 (1980). |
Botstein et al., “Making Mutations in vitro and Putting Them Back into Yeast,” Miami Winter Symposia 19:265-274 (1982). |
Brinster et al., “Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs,” Proc. Nat. Acad. Sci. USA 82:4438-4442 (1985). |
Broach, “The Yeast Plasmid 2μ Circle,” Cell 28:203-204 (1982). |
Broach, “The Yeast Plasmid 2μ Circle,” in The Molecular Biology of the Yeast Saccharomyces: Life Cycle and Inheritance, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp. 445-470 (1981). |
Bullock et al., “Techniques in Immunocytochemistry,” Academic Press, Orlando, FL vol. 1(1982), vol. 2 (1983), vol. 3 (1985). |
Campbell, “Monoclonal Antibody Technology: Laboratory Techniques in Biochemistry and Molecular Biology,” Elsevier Science Publishers, Amsterdam, The Netherlands (1984) (Table of contents only). |
Capecchi, “Altering the Genome by Homologous Recombination,” Science 244:1288-1292 (1989). |
Capecchi, “High Efficiency Transformation by Direct Microinjection of DNA into Cultured Mammalian Cells,” Cell 22:479-488 (1980). |
Cavailles et al., “Interaction of proteins with transcriptionally active estrogen receptors,” Proc. Natl. Acad. Sci. USA 91:10009-10013 (1994). |
Cavailles et al., “Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor,” EMBO Journal 14(15):3741-3751 (1995). |
Centiempo, “Prokaryotic gene expression in vitro: transcription-translation copuled systems,” Biochimie 68:505-515 (1986). |
Chalepakis et al., “Differential Gene Activation by Glucocorticoids and Progestins through the Hormone Regulatory Element of Mouse Mammary Tumor Virus,” Cell 53:371-382 (1988). |
Chard, “An Introduction to Radioimmunoassay and Related Techniques” Elsevier Science Publishers, Amsterdam, The Netherlands (1986) (Table of contents only). |
Chater et al., “Streptomyces φC31-Like Phages: Cloning Vectors, Genome Changes and Host Range,” in Sixth International Symposium on Actinomycetes, Akademiai Kaido, Budapest, Hungary, pp. 45-52 (1986). |
Chen and Okayama, “High-Efficiency Transformation of Mammalian Cells by Plasmid DNA,” Molecular and Cellular Biology 7(8):2745-2752 (1987). |
Chiba et al., “Two human homologues of Saccharomyces cerevisiae SW12/SNF2 and Drosophila brahma are transcriptional coactivators cooperating with the estrogen receptor and the retinoic acid receptor,” Nucleic Acids Research 22:1815-1820 (1994). |
Chowdhury et al., “Long-term Improvement of Hypercholesterolemia After ex Vivo Gene Therapy in LDLF-Deficient Rabbits,” Science 254:1802-1805 (1991). |
Chrivia et al., “Phosphorylated CREB binds specifically to the nuclear protein CBP,” Nature 365:855-859 (1993). |
Chu et al., “Electroporation for the efficient transfection of mammalian cells with DNA,” Nucleic Acids Research 15:1311-1326 (1987). |
Chu et al., “Efficiency of Cytoplasmic Delivery by pH-Sensitive Liposomes to Cells in Culture,” Pharmaceutical Research 7:824-834 (1990). |
Conneely et al., “Promoter specific activating domains of the chicken progesterone receptor,” in Gene Regulation by Steroid Hormones IV, edited by Roy and Clark, New York, Berlin, Heidelberg, London, Paris, Tokyo: Springer-Verlag, pp. 220-223 (1989). |
Cooney et al., “Multiple Mechanisms of Chicken Ovalbumin Upstream Promoter Transcription Factor-dependent Repression of Transactivation by the Vitamin D, Thyroid Hormone, and Retinoic and Retinoic Acid Receptors,” J. Biol. Chem. 268:4152-4160 (1993). |
Courey and Tjian, “Analysis of Sp1 In Vivo Reveals Multiple Transcriptional Domains, Including a Novel Glutamine-Rich Activation Motif,” Cell 55:887-898 (1988). |
Creighton, Proteins: Structures and Molecular Principles pp. 79-86, W.H. Freeman and Co., New York (1983). |
Cristiano et al., “Hepatic Gene Therapy: Adenovirus Enhancement of Receptor-Mediated Gene Delivery and Expression in Primary Hepatocytes,” Proc. Natl. Acad. Sci. USA 90:2122-2126 (1993). |
Curiel et al., “Adenovirus Enhancement of Transferrin-polylysine-mediated Gene Delivery,” Proc. Natl. Acad. Sci. USA 88:8850-8854 (1991). |
Curiel et al., “Gene Transfer to Respiratory Epithelial Cells via the Receptor-mediated Endocytosis Pathway,” Am. J. Respir. Cell. Mol. Biol. 6:247-252 (1992). |
DeMarzo et al., “Effects of the Steroid Antagonist RU486 on Dimerization of the Human Progesterone Receptor,” Biochemistry 31:10491-10501 (1992). |
Denner et al., “Regulation of Progesterone Receptor-Mediated Transcription by Phosphorylation,” Science 250:1740-1743 (1990). |
Durfee et al., “The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit,” Genes and Development 7:555-569 (1993). |
Dynlacht et al., “Isolation of Coactivators Associated with the TATA-Binding Protein that Mediate Transcriptional Activation,” Cell 66:563-576 (1991). |
El-Ashry et al., “Human Progesterone Receptor Complexed with the Antagonist RU 486 Binds to Hormone Response Elements in a Structurally Altered Form,” Molecular Endocrinology 3:1545-1558 (1989). |
Engvall et al., “Enzyme-Linked Immunosorbent Assay, ELISA. III. Quantitation of Specific Antibodies by Enzyme-Labeled Anti-Immunoglobulin in Antigen-Coated Tubes,” J. Immunology 109:129-135 (1972). |
Felgner and Ringold, “Cationic liposome-mediated transfection,” Nature 337:387-388 (1989). |
Felgner et al., “Lipofection: A Highly Efficient, Lipid-mediated DNA-transfection Procedure,” Proc. Natl. Acad. Sci. USA 84:7413-7417 (1987). |
Flanagan et al., “A mediator required for activation of RNA polymerase II transcription in vitro,” Nature 350:436-438 (1991). |
Giguere et al., “Functional Domains of the Human Glucocorticoid Receptor,” Cell 46:645-652 (1986). |
Gilman et al., “Isolation of sigma-28-specific promoters from Bacillus subtilis DNA,” Gene 32:11-32:11-20 (1984). |
Glick and Whitney, “Factors affecting the expression of foreign proteins in Escherichia coli,” Journal of Industrial Microbiology 1:277-282 (1987). |
Goding, “Conjugation of Antibodies with Fluorochromes: Modifications to the Standard Methods,” J. Immunological Methods 13:215-226 (1976). |
Gold et al., “Translational Initiation in Prokaryotes,” Ann. Rev. Microbiol. 35:365-403 (1981). |
Gottesman, “Bacterial Regulation: Global Regulatory Networks,” Ann. Rev. Genet. 18:415-441 (1984). |
Gronemeyer, “Transcription Activation by Estrogen and Progesterone Receptors,” Ann. Rev. Genet. 25:89-123 (1991). |
Haensler and Szoka, “Haensler and Szoka, Synthesis and Characterization of a Trigalactosylated Bisacridine Compound to Target DNA to Hepatocytes,” Bioconjugate Chem. 4:85-93 (1993). |
Halachmi et al., “Estrogen Receptor-Associated Proteins: Possible Mediators of Hormone-Induced Transcription,” Science 264:1455-1458 (1994). |
Hamer and Walling, “Regulation In Vivo of a Cloned Mammalian Gene: Cadmium Induces the Transcription of a Mouse Metallothionein Gene in SV40 Vectors,” J. of Molecular and Applied Genetics 1:273-288 (1982). |
Hammer et al., “Spontaneous Inflammatory Disease in Transgenic Rats Expressing HLA-B27 and Human β2m: An Animal Model of HLA-B27-Associated Human Disorders,” Cell 63:1099-1112 (1990). |
Haynes et al., “The bromodomain: a conserved sequence found in human, Drosophila and yeast proteins,” Nucleic Acids Research 20:2603 (1992). |
Helin et al., “Inhibition of E2F-1 Trasactivation by Direct Binding of the Retinoblastoma Protein,” Molecular and Cellular Biology 13:6501-6508 (1993). |
Hillier et al., “WashU-Merck EST Project,” EMBL Database Entry HS15927, Accession No. T56159; Mar. 1, 1995. |
Houdebine and Chourrout, “Transgenesis in Fish,” Experientia 47:891-897 (1991). |
Hurby et al., “Application of Synthetic Peptides: Antisense Peptides”, in Synthetic Peptides: A User's Guide, edited by Gregory A. Grant, W.H. Freeman, NY, pp. 289-307 (1992). |
Izaki, Jpn. J. Bacteriol. 33:729-742 (1978). |
Wilchek and Jakoby, “The Literature on Affinity Chromatography,” Methods in Enzymology 34:3-10 (1974). |
Jasny, “Insect Viruses Invade Biotechnology,” Science 238:1653 (1987). |
John et al., “Plasmids as Epidemiologic Markers in Nosocomial Gram-Negative Bacilli: Experience at a University and Review of the Literature,” Rev. Infect. Dis. 8:693-704 (1986). |
Johnston and Hopper, “Isolation of the yeast regulatory gene GAS4 and analysis of its dosage effects on the galactose/melibiose regulon,” Proc. Natl. Acad. Sci. USA 79:6971-6975 (1982). |
Joyner et al., “Production of a mutation in mouse En-2 gene by homologous recombination in embryonic stem cells,” Nature 338:153-156 (1989). |
Kaneda et al., “The Improved Efficient Method for Introducing Macromolecules into Cells Using HVJ (Sendai Virus) Liposomes with Gangliosides,” Experimental Cell Research 173:56-69 (1987). |
Kaneda et al., “Increased Expression of DNA Cointroduced with Nuclear Protein in Adult Rat Liver,” Science 243:375-378 (1989). |
Kashanchi et al., “Direct interaction of human TFIID with the HIV-1 transactivator Tat,” Nature 367:295-299 (1994). |
Kasprzak et al., “Location of a Contact Site Between Actin and Myosin in the Three-Dimensional Structure of the Acto-S1 Complex,” Biochemistry 28:9230-9238 (1989). |
Kastner et al., “Two distinct estrogen-related promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B,” EMBO J. 9:1603-1614 (1990). |
Kendall and Cohen, “Plasmid Transfer in Streptomyces lividans: Identification of a kil-kor System Associated with the Transfer Region of PIJ101,” Journal of Bacteriology 169:4177-4183 (1987). |
Klein-Hitpass et al., “The Progesterone Receptor Stimulates Cell-Free Transcription by Enhancing the Formation of a Stable Perinitiation Complex,” Cell 60:247-257 (1990). |
Laurent et al., “The yeast SNF2/SW12 protein has DNA-stimulated ATPase activity required for transcriptional activation,” Genes and Development 7:583-591 (1993). |
Lengendre and Szoka, “Cyclic Amphiphatic Peptide-DNA Complexes Mediate High-efficiency Transfection of Adherent Mammalian Cells,” Proc. Natl. Acad. Sci. USA 90:893-897 (1993). |
Legendre and Szoka, “Delivery of Plasmid DNA into Mammalian Cell Lines Using pH-Sensitive Liposomes: Comparison with Cationic Liposomes,” Pharmaceutical Research 9:1235-1242 (1992). |
Le Douarin et al., “The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protien T18,” EMBO J. 14:2020-2023 (1995). |
Lutz et al., “The Distribution of Two hnRNP-Associated Protein Defined by a Monoclonal Antibody is Altered in Heat-Shocked HeLa Cells,” Exp. Cell Res. 175:109-124 (1988). |
Maniatis, “Ch. 11—Recombinant DNA Procedures in the Study of Eukaryotic Genes,” in Cell Biology: A Comprehensive Treatise, vol. 3, Gene Sequence Expression, Academic Press, NY, pp. 563-608 (1980). |
McDonnell et al., “Identification of a negative regulatory function for steroid receptors,” Proc. Natl. Acad. Sci. USA 89:10563-10567 (1992). |
McKnight, “Functional Relationships between Transcriptional Control Signals of the Thymidine Kinase Gene of Herpes Simplex Virus,” Cell 31:355-365 (1982). |
Meyer et al., “Agonistic and antagonistic activities of RU486 on the functions of the human progesterone receptor,” EMBO J. 9:3923-3932 (1990). |
Meyer et al., “Steroid Hormone Receptors Compete for Factors That Mediate Their Enhancer Function,” Cell 57:433-442 (1989). |
Miller, “Human gene therapy comes of age,” Nature 357:455-460 (1992). |
Miller et al., “An Insect Baculovirus Host-Vector System for High-Level Expression of Foreign Genes,” in Genetic Engineering: Principles and Methods, edited by Setlow et al., Plenum Press, 8:277-298 (1986). |
Muchardt and Yaniv, “A human homologue of Saccharomyces cerevisiae SNF2/SW12 and Drosophila brm genes potentiates transcriptional activation by the glucocorticoid receptor,” EMBO J. 12:4279-4290 (1993). |
Mulligan, “The Basic Science of Gene Therapy,” Science 260:926-932 (1993). |
Nawaz et al., “The yeast SIN3 gene product negatively regulates the activity of the human progesterone receptor and positively regulates the activities of GAL4 and the HAP1 activator,” Mol. Gen. Genet. 245:724-733 (1994). |
Nelson et al., “Detection of Acridinium Esters by Chemiluminescence,” in Nonisotopic DNA Probe Techniques, Kricka editor, Academic Press, Inc., San Diego, pp. 275-310 (1992). |
Okayama and Berg, “A cDNA Cloning Vector That Permits Expression of cDNA Inserts in Mammalian Cells,” Molecular and Cellular Biology 3:280-289 (1983). |
Onate et al., “Sequence and characterization of a coactivator for the steorid hormone receptor superfamily,” Science 270:1354-1357 (1995). |
Pereira et al., “The 56 kDa Androgen Protein is an Aldehyde Dehydrogenase,” Biochemical and Biophysical Research Communications 175:831-838 (1991). |
Pursel et al., “Genetic Engineering of Livestock,” Science 244:1281-1288 (1989). |
Raineri et al., “Analysis of human immunodefiency virus type 1 promoter insertion in vivo,” EMBL Database Entry HS19179, Accession No. U19179; Apr. 13, 1995. |
Sartorius et al., “A Third Transaction Function (AF3) of Human Progesterone Receptors Located in the Unique N-Terminal Segment of the B-isoform,” Molecular Endocrinology 8:1347-1360 (1994). |
Sauer et al., “Control of transcription by Kruppel through interactions with TFIIB and TFIIEβ,” Nature 375:162-164 (1995). |
Schild et al., “A nucleosome-dependent static loop potentiates estrogen-regulated transcription from the Xenopus vitellogenin B1 promoter in vitro,” EMBO J. 12:423-433 (1993). |
Seol et al., “Isolation of Proteins That Interact Specifically with the Retinoid X Receptor: Two Novel Orphan Receptors,” Molecular Endocrinology 9:72-85 (1995). |
Shemshedini et al., “In Vitro Activity of the Transcription Activation Functions of the Progesterone Receptor,” J. Biol. Chem. 267:1834-1839 (1992). |
Silver et al., “Amino terminus of the yeast GAL4 gene product is sufficient for nuclear localization,” Proc. Natl. Acad. Sci. USA 81:5951-5955 (1984). |
Simons et al., “Gene Transfer Into Sheep,” Bio/Technology 6:179-183 (1988). |
Singh et al., “A role for retinoblastoma protein in potentiating transcriptional activation by the glucocorticoid receptor,” Nature 374:562-565 (1995). |
Smith et al., “Modulation of the ligand-dependent activation of the human estrogen receptor by hormone and antihormone,” Proc. Natl. Acad. Sci. USA 90:6120-6124 (1993). |
St. Groth and Scheidegger, “Production of Monoclonal Antibodies: Strategy and Tactics,” J. Immunol. Methods 35:1-21 (1980). |
Sternberger et al., “The Unlabeled Antibody Enzyme Method of Immunohistochemistry,” Histochemistry and Cytochemistry 18:315-333 (1970). |
Stringer et al., “Direct and selective binding of an acidic transcriptional activation domain to the TAT-box factor TFIID,” Nature 345:783-785 (1990). |
Tasset et al., “Distinct Classes of Transcriptional Activating Domains Function by Different Mechanisms,” Cell 62:1177-1187 (1990). |
Tijssen, “Practice and Theory of Enzyme Immunoassays: Laboratory Techniques in Biochemistry and Molecular Biology”, Elsevier Science Publishers, Amsterdam, The Netherlands (1985) (Table of contents only). |
Tora et al., “The N-terminal region of the chicken progesterone receptor specifies target gene activation,” Nature 333:185-188 (1988). |
Tora et al., “The Human Estrogen Receptor has Two Independent Nonacidic Transcriptional Activation Functions,” Cell 59:477-487 (1989). |
Truss et al., “Hormone induces binding of receptors and transcription factors to a rearranged nucleosome on the MMTV promoter in vivo,” EMBO J. 14:1737-1751 (1995). |
Tsai et al., “Recombinant Human Glucocorticoid Receptor Induces Transcription of Hormone Response Genes in Vitro,” J. Biol. Chem. 265:17055-17061 (1990). |
Tsai and O'Malley, “Molecular Mechanisms of Action of Steroid/Thyroid Receptor Superfamily Members,” Ann. Rev. Biochem. 63:451-486 (1994). |
Tung et al., “Antagonist-Occupied Human Progesterone B-Receptors Activate Transcription without Binding to Progesterone Response Elements and Are Dominantly inhibited by A-Receptors,” Molecular Endocrinology 7:1256-1265 (1993). |
Ulmanen et al., “Transcription and Translation of Foreign Genes in Bacillus subtilis by the Aid of a Secretion Vector,” Journal of Bacteriology 162:176-182(1985). |
Umesono et al., “Direct Repeats as Selective Response Elements for the Thyroid Hormone, Retinoic Acid, and Vitamin D3 Receptors,” Cell 65:1255-12661 (1991). |
Vegeto et al., “The Mechanism of RU486 Antagonism Is Dependent on the Conformation of the Carboxy-Terminal Tail of the Human Progesterone Receptor,” Cell 69:703-713 (1992). |
Voegel et al., “TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors,” EMBO J. 15:3667-3675 (1996). |
Ward et al., “Construction and characterization of a series of multi-copy promoter-probe plasmid vectors for Streptomyces using the aminoglycoside phosphotransferase gene from Tn5 as indicator,” Mol. Gen. Genet. 203:468-478 (1986). |
Wei et al., “Immunologic Analysis of Human Breast Cancer Progesterone Receptors. 2. Structure, Phosphorylationn, and Processing,” Biochemistry 26:6262-6272 (1987). |
Weigel et al., “Ligands Induce Conformational Changes in the Carboxyl-Terminus of Progesterone Receptors which are Detected by a Site-Directed Antipeptide Monoclonal Antibody,” Molecular Endocrinology 6:1585-1597 (1992). |
Dreborg et al., “Ch. 10—The chemistry and standardization of allergens,” in Handbook of Experimental Immunology—Volume 1: Immunochemistry, 4th Ed., edited by Weir et al., Blackwell Scientific Publications, Oxford, England, pp. 10.1-10.28 (1986). |
Wilson et al., “Clinical Protocol: Ex Vivo Gene Therapy of Familial Hypercholesterolemia,” Human Gene Therapy 3:179-222 (1991). |
Wolff et al., “Direct Gene Transfer into Mouse Muscle In Vivo,” Science 247:1465-1468 (1990). |
Wu and Wu, “Receptor-mediated in Vitro Gene Transformation by a Soluble DNA Carrier System,” J. Biol. Chem. 262:4429-4432 (1987). |
Wu et al., “Receptor-mediated Gene Delivery in Vivo,” J. Biol. Chem. 266:14338-14342 (1991). |
Yang et al., “In Vivo and In Vitro Gene Transfer to Mammalian Somatic Cells by Particle Bombardment,” Proc. Natl. Acad. Sci. USA 87:9568-9572 (1990). |
Yoshinaga et al., “Roles of SWI1, SW12, and SW13 Proteins for Transcriptional Enhancement by Steroid Receptors,” Science 258:1598-1604 (1992). |
Zawel and Reinberg, “Common Themes in Assembly and Function of Eukaryotic Transcription Complexes,” Ann. Rev. Biochem. 64:533-561 (1995). |
Zhu et al., “Systemic Gene Expression After Intravenous DNA Delivery into Adult Mice,” Science 261:209-211 (1993). |